BlackRock Amends Amphastar Pharma Stake (SC 13G/A)
Ticker: AMPH · Form: SC 13G/A · Filed: Jan 23, 2024 · CIK: 1297184
| Field | Detail |
|---|---|
| Company | Amphastar Pharmaceuticals, Inc. (AMPH) |
| Form Type | SC 13G/A |
| Filed Date | Jan 23, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in Amphastar Pharma, signaling a minor portfolio adjustment.**
AI Summary
BlackRock, Inc. filed an amended SC 13G/A on January 23, 2024, indicating a change in its ownership stake in Amphastar Pharmaceuticals, Inc. as of December 31, 2023. This filing, Amendment No. 8, shows BlackRock's updated passive investment position in the pharmaceutical company. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in its confidence or strategy regarding Amphastar Pharmaceuticals, potentially influencing other investors.
Why It Matters
This filing updates BlackRock's passive ownership in Amphastar Pharmaceuticals, providing transparency on a major institutional investor's position. It can influence market perception and investor sentiment towards Amphastar.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate significant risk to the company or its stock.
Analyst Insight
Smart investors would note BlackRock's continued passive interest in Amphastar Pharmaceuticals, but recognize this routine update doesn't signal a major strategic shift. They might monitor future filings for more significant changes in ownership percentage or activist intent.
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person and institutional investor
- Amphastar Pharmaceuticals, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 23, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 8 (number) — the specific amendment number of this filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G (Amendment No: 8)' sections.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as indicated under the 'FILED BY' section and 'Names of reporting persons. BlackRock, Inc.' on the cover page.
Which company's securities are being reported on?
The securities of Amphastar Pharmaceuticals, Inc. are being reported on, as stated under 'SUBJECT COMPANY: COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.' and 'AMPHASTAR PHARMACEUTICALS INC (Name of Issuer)'.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified on the cover page.
Under which rule is this Schedule 13G filed?
This Schedule 13G is filed under Rule 13d-1(b), as indicated by the 'X' next to '[X] Rule 13d-1(b)' on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 23, 2024 regarding Amphastar Pharmaceuticals, Inc. (AMPH).